Ranibizumab and Bevacizumab for Diabetic Macular Edema

NCT01610557 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Bevacizumab

Sponsor

National Eye Institute (NEI)

Collaborators

[object Object]